molecular
techniqu
repres
major
step
forward
diagnosi
viral
respiratori
infect
consid
highli
sensit
specif
compar
convent
techniqu
studi
two
nucleic
acid
amplif
test
naat
compar
convent
method
immunofluoresc
viral
cultur
aim
work
discuss
clinic
interpret
result
obtain
naat
basi
twodecad
experi
group
literatur
eighti
nasopharyng
aspir
collect
children
six
year
attend
acut
respiratori
ill
pediatr
emerg
room
third
level
hospit
naat
test
seeplex
clart
show
overal
higher
perform
regard
sensit
respect
compar
seeplex
clart
system
tripl
number
multipl
detect
seeplex
respiratori
tract
infect
frequent
caus
ill
children
viral
etiolog
van
de
pol
et
al
mahoni
raymond
et
al
vallier
renaud
common
respiratori
virus
influenza
viru
fluav
influenza
b
viru
flubv
human
parainfluenzaviru
human
respiratori
synciti
viru
rsv
human
metapneumoviru
hmpv
enterovirus
ev
rhinovirus
rv
human
coronavirus
hcov
human
bocavirus
hbov
human
adenovirus
adv
infect
caus
respiratori
virus
show
similar
clinic
manifest
microbiolog
studi
must
perform
identifi
etiolog
caliendo
pagarola
sune
diagnosi
viral
respiratori
infect
tradit
perform
use
convent
method
base
viral
cultur
vc
antigen
detect
immunofluoresc
assay
vc
remain
goldstandard
requir
train
personnel
result
may
take
day
virus
multipli
cultur
techniqu
quick
allow
qualiti
control
sampl
need
big
expertis
interpret
addit
avail
virus
lack
sensit
other
ginocchio
mcadam
nucleic
acid
amplif
test
naat
becom
altern
offer
high
sensit
specif
compar
convent
method
elnifro
et
al
mahoni
ginocchio
mcadam
numer
test
develop
use
multiplex
pcr
detect
sever
virus
includ
detect
either
vc
immunoassay
although
pcrbase
techniqu
initi
limit
type
virus
could
detect
singl
test
liolio
et
al
coira
et
al
bellaupujol
et
al
freymuth
et
al
numer
multiplex
pcr
test
develop
allow
virus
detect
singl
assay
amplicon
detect
perform
hybrid
use
microarray
henrickson
et
al
raymond
et
al
cannon
et
al
renoi
et
al
frobert
et
al
culebra
et
al
pillet
et
al
semiconductorbas
dna
microspher
mahoni
et
al
sever
respiratori
viru
panel
rvp
commerci
xtag
rvp
luminex
mahoni
et
al
pabbaraju
et
al
gadsbi
et
al
baladallasat
et
al
kim
et
al
pillet
et
al
multicod
plx
rvp
eragen
baladallasat
et
al
resplex
ii
qiagen
li
et
al
baladallasat
et
al
pillet
et
al
naat
multiplex
ligationdepend
probe
amplif
system
mlpa
reijan
et
al
bruijnesteijn
van
coppenraet
et
al
pillet
et
al
dual
prime
oligonucleotid
dpo
system
roh
et
al
bruijnesteijn
van
coppenraet
et
al
zhang
et
al
cho
et
al
kim
et
al
pillet
et
al
pcrbase
system
gener
diagnost
result
within
one
work
day
implement
laboratori
routin
may
costeffect
studi
assess
two
multiplex
pcrbase
techniqu
commerci
avail
name
clart
seeplex
naat
studi
previous
roh
et
al
bruijnesteijn
van
coppenraet
et
al
renoi
et
al
frobert
et
al
zhang
et
al
cho
et
al
culebra
et
al
kim
et
al
pillet
et
al
present
work
compar
also
two
convent
method
diagnosi
viral
respiratori
infect
aim
work
discuss
clinic
interpret
result
obtain
naat
basi
twodecad
experi
convent
method
benefit
pitfal
molecular
techniqu
also
discuss
eighti
nasopharyng
aspir
collect
children
six
year
attend
acut
respiratori
ill
pediatr
emerg
room
third
level
hospit
octob
novemb
februari
march
consecut
specimen
cellsfield
microscop
observ
suffici
residu
volum
ml
select
specimen
process
within
work
day
store
weekend
maximum
hr
epidemiolog
data
collect
sampl
assess
use
dfa
metapneumoviru
identif
kit
diagnost
hybrid
athen
oh
rsv
direct
biom
erieux
marcyletoil
franc
respiratori
panel
viral
screen
identif
ifa
kit
millipor
light
diagnost
temecula
ca
detect
adv
fluav
flubv
rsv
accord
manufactur
instruct
viral
isol
sampl
cultur
use
six
cell
line
mdck
rd
vircel
sl
santa
fe
granada
spain
cell
cultur
examin
daili
cytopath
effect
two
week
definit
identif
assess
nucleic
acid
extract
ml
clinic
sampl
use
viru
mini
kit
bio
robot
qiagen
hilden
germani
accord
manufactur
instruct
extract
store
use
molecular
viral
detect
perform
use
two
naat
seeplex
ace
detect
kit
seegen
seoul
south
korea
clart
pneumovir
kit
genomica
madrid
spain
follow
manufactur
instruct
seeplex
method
base
dpo
system
amplicon
detect
perform
fulli
autom
capillari
electrophoresi
separ
multina
shimadzubiotech
kyoto
japan
method
provid
result
six
hour
clart
system
base
microarray
technolog
analysi
result
hybrid
pattern
perform
use
optic
equip
clondiag
chip
technolog
jena
germani
method
provid
result
hr
assay
detect
fluav
flubv
adv
hmpv
rsva
rsvb
rv
seeplex
also
detect
differenti
speci
rv
b
clart
also
detect
hbov
influenza
c
viru
flucv
ev
ab
differenti
hmpva
hmpvb
assay
includ
intern
control
detect
amplif
inhibit
naat
gave
qualit
result
epidemiolog
data
age
sex
date
sampl
collect
clinic
diagnosi
collect
statist
analys
perform
use
vassar
stat
websit
http
vassarstatsnet
work
result
consid
clinic
relev
true
posit
respiratori
viru
detect
andor
vc
regardless
naat
result
naat
criterion
posit
rang
virus
detect
differ
depend
viru
method
use
tabl
sampl
includ
studi
viral
detect
obtain
sampl
ifvc
seeplex
clart
respect
either
naat
yield
posit
result
sampl
neg
ifvc
three
sampl
neg
techniqu
assess
tabl
seeplex
clart
detect
virus
ifvc
respect
rv
virus
frequent
detect
pcr
although
two
recov
ifvc
tabl
multipl
detect
obtain
sampl
naat
ifvc
achiev
multipl
recoveri
case
inhibit
observ
sampl
seeplex
clart
two
sampl
inhibit
method
accord
establish
criterion
posit
sampl
consid
posit
respiratori
viru
ifvc
regardless
naat
result
two
naat
viral
detect
coincid
ifvc
naat
sampl
coincid
result
found
ifvc
one
naat
sampl
one
seeplex
clart
three
sampl
posit
viral
detect
ifvc
neg
naat
anoth
posit
sampl
inhibit
three
posit
sampl
ifvc
addit
virus
detect
seeplex
clart
rv
detect
sampl
posit
naat
n
one
addit
viru
adv
overal
signific
virus
detect
sinc
ev
detect
one
naat
includ
calcul
consid
remain
signific
virus
rel
sensit
ifvc
seeplex
clart
respect
tabl
ii
naat
achiev
high
rate
multipl
viru
detect
correspond
seeplex
clart
regard
virus
identifi
one
techniqu
clart
detect
hbov
sampl
multipl
detect
seeplex
detect
five
sampl
correspond
multipl
detect
three
case
follow
criterion
posit
previous
establish
four
sampl
consid
real
multipl
infect
tabl
iii
regard
clinic
demograph
analysi
relev
data
obtain
total
number
sampl
assess
specimen
belong
patient
upper
lower
respiratori
tract
infect
urti
lrti
respect
viral
distribut
follow
definit
pattern
although
rsv
adv
predominantli
detect
patient
lrti
urti
respect
statist
signific
associ
found
virus
detect
clinic
group
main
find
present
studi
naat
use
detect
respiratori
virus
yield
differ
result
expect
naat
detect
virus
convent
techniqu
question
remain
howev
whether
extra
sensit
provid
reliabl
inform
etiolog
infect
clart
highest
detect
rate
result
agre
convent
result
often
seeplex
could
due
differ
rang
virus
cover
techniqu
although
naat
investig
method
use
gold
standard
differ
roh
et
al
bruijnesteijn
van
coppenraet
et
al
frobert
et
al
zhang
et
al
cho
et
al
culebra
et
al
kim
et
al
pillet
et
al
import
drawback
compar
naat
therefor
lack
real
gold
standard
convent
pcrbase
method
yield
similar
result
rsv
adv
rsv
sensit
vc
equal
sensit
molecular
method
adv
isol
cell
cultur
usual
requir
poor
sensit
number
adv
isol
coincid
detect
molecular
method
find
coincid
experi
group
last
two
decad
report
author
dunn
et
al
mahoni
doan
et
al
cho
et
al
molecular
techniqu
key
diagnos
larg
rang
new
virus
incap
multipli
vc
hcov
hbov
new
speci
rv
consid
virus
detect
pcr
correspond
rv
hmpv
flucv
hbov
previou
studi
naat
larg
increas
number
rv
detect
freymuth
et
al
li
et
al
mahoni
et
al
bruijnesteijn
van
coppenraet
et
al
cho
et
al
naat
alway
give
result
inhibit
amplif
reaction
drawback
mainli
specimen
extract
protocol
naat
test
yield
inhibit
result
fact
inhibit
sampl
differ
two
techniqu
despit
extract
suggest
method
probabl
main
caus
pcr
inhibit
failur
naat
give
result
may
also
lack
specif
target
target
includ
reaction
case
human
herpesviru
also
variabl
respiratori
virus
therefor
laboratori
especi
reli
naat
need
constantli
review
virus
includ
assay
use
ogilvi
naat
creat
new
scenario
diagnosi
viral
respiratori
infect
high
yield
multipl
viral
detect
kuyper
et
al
madhi
klugman
leland
ginocchio
compar
seeplex
clart
system
tripl
number
multipl
detect
differ
design
particularli
concern
primer
amplif
condit
may
contribut
dispar
high
rate
multipl
detect
may
explain
pediatr
popul
agreement
author
roh
et
al
kim
et
al
bruijnesteijn
van
coppenraet
et
al
frobert
et
al
zhang
et
al
import
remain
question
clinic
relev
result
obtain
naat
cover
broad
rang
etiolog
agent
quick
techniqu
may
especi
use
immunosupress
critic
ill
patient
although
clinic
impact
yet
well
establish
garbino
et
al
schnell
et
al
howev
naat
detect
viral
nucleic
acid
regardless
presenc
viral
antigen
infect
virus
pagarola
sune
elnifro
et
al
mahoni
ginocchio
mcadam
jansen
et
al
although
viral
load
may
use
predict
correl
viru
infecti
process
wellestablish
respiratori
viral
infect
kuyper
et
al
debiaggi
et
al
preval
specif
virus
base
naat
differ
symptomat
asymptomat
children
debiaggi
et
al
buller
virus
rsv
usual
associ
clinic
ill
consid
etiolog
agent
patient
respiratori
symptom
contrast
virus
rv
hcov
hbov
seem
frequent
found
asymptomat
children
debiaggi
et
al
meriluoto
et
al
although
studi
issu
requir
manag
patient
requir
report
result
within
clinic
relev
timescal
microbiolog
laboratori
take
consider
choos
diagnost
test
naat
faster
cultur
requir
two
day
minimum
naat
test
turn
around
time
six
nine
hour
howev
naat
faster
immunochromatographi
rapid
antigen
detect
test
certain
respiratori
virus
provid
result
high
specif
within
min
mandel
et
al
epidem
situat
use
techniqu
first
step
detect
virus
influenza
viru
rsv
may
acceler
result
bring
simplic
laboratori
neg
result
would
requir
analysi
buller
anoth
import
point
naat
antigen
detect
techniqu
detect
specif
virus
investig
virus
may
relat
clinic
process
detect
combin
sever
method
diagnosi
viral
respiratori
infect
still
great
option
howev
laboratori
facil
personnel
requir
perform
wide
rang
techniqu
antigen
detect
test
viru
isol
molecular
test
naat
particularli
use
detect
new
virus
give
quick
result
howev
interpret
molecular
test
alway
straightforward
clinic
virologist
must
consid
pro
con
techniqu
use
clinic
impact
result
